Skip to main content
Hemant Murthy, MD, Hematology, Jacksonville, FL, Mayo Clinic Hospital in Florida

HemantSreenivasaMurthyMD

Hematology Jacksonville, FL

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Associate Professor of Medicine- Division of Hematologic Malignancies and Bone Marrow Transplant https://www.mayoclinic.org/biographies/murthy-hemant-s-m-d/bio-20464551

Dr. Murthy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Murthy's full profile

Already have an account?

Summary

  • Dr. Hemant Murthy is a hematologist in Jacksonville, FL and is affiliated with Mayo Clinic Hospital in Florida and Associate Professor of medicine at the Mayo Clinic. He specializes in hematologic oncology and is experienced in immunotherapy, hematopoietic stem cell transplantation, car-T and immunotherapy, and leukemia and myeloid disorders

Education & Training

  • H. Lee Moffitt Cancer Center and Research Institute
    H. Lee Moffitt Cancer Center and Research InstituteBone marrow transplant , 2015 - 2016
  • Vidant Medical Center/East Carolina University
    Vidant Medical Center/East Carolina UniversityFellowship, Hematology and Medical Oncology, 2012 - 2015
  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemFellowship, Hospice and Palliative Medicine, 2011 - 2012
  • SUNY Health Science Center at Brooklyn
    SUNY Health Science Center at BrooklynResidency, Internal Medicine, 2008 - 2011
  • St. George's University School of Medicine
    St. George's University School of MedicineClass of 2008
  • State University of New York at Binghamton
    State University of New York at BinghamtonBS, Chemistry, 1998 - 2002

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2015 - 2025
  • NC State Medical License
    NC State Medical License 2012 - 2016
  • VA State Medical License
    VA State Medical License 2011 - 2014
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Hospice and Palliative Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Resident/ Fellow Scholarship VCU Deparment of Medicine, 2012
  • AAHPM HPNA Annual Assembly Palliative Medicine Access Fund Scholarship 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Pharmacokinetic and Clinical Outcomes When Ideal Body Weight Is Used to Dose Busulfan in Obese Hematopoietic Stem Cell Transplant Recipients  
    Jack W Hsu, Hemant S Murthy, Nature

Abstracts/Posters

  • Impact of Renal Dysfunction Measured By Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)
    Hemant S. Murthy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Diet Quality of Long-Term Allogeneic and Autologous Stem Cell Transplant (HCT) Survivors
    Hemant S. Murthy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Efficacy of Allogeneic Hematopoietic Cell Transplantation (HCT) in Sickle Cell Disease: Results of a Systematic Review/Meta-Analysis
    Hemant S. Murthy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • The Perils Of Palliative Care- Recognizing When Palliative Interventions Are The Cause Of Symptom Burden. 
    Annual Assembly of the American Academy of Hospice and Palliative Medicine and Hospice
  • Lymphedema- A Growing Problem. 
    Department of Hematology, Oncology and Palliative Medicine, Virginia Commonwealth University

Authored Content

  • Recent Research Brings Improved Outcomes in Allogeneic Hematopoietic Cell TransplantationFebruary 2021
  • State of the science: High-priority transplant trials for nonmalignant diseaseApril 2015

Press Mentions

  • Looking Back on 2020: A Successful Year of Research at Mayo Clinic in Florida
    Looking Back on 2020: A Successful Year of Research at Mayo Clinic in FloridaJanuary 5th, 2021
  • FDA Warns of Rare Secondary Cancer Risk with CAR-T Therapies
    FDA Warns of Rare Secondary Cancer Risk with CAR-T TherapiesJanuary 27th, 2024
  • FDA Says CAR-T Therapy for Cancer Treatment May Increase Cancer Risk
    FDA Says CAR-T Therapy for Cancer Treatment May Increase Cancer RiskJanuary 24th, 2024
  • Join now to see all

Professional Memberships

Hospital Affiliations